Springer Nature
Browse
13048_2020_691_MOESM1_ESM.tif (715.14 kB)

Additional file 1 of A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer

Download (715.14 kB)
figure
posted on 2020-09-01, 04:01 authored by Daniel C. Beachler, Francois-Xavier Lamy, Leo Russo, Devon H. Taylor, Jade Dinh, Ruihua Yin, Aziza Jamal-Allial, Samuel Dychter, Stephan Lanes, Patrice Verpillat
Additional file 1: Figure S1. Example of a hypothetical patient “A” progressing from early to advanced stage ovarian cancer and definition of index date. Most patients (96.7%) in our cohort were classed as advanced stage at diagnosis. This hypothetical example would have been classified in those who “progressed from early to advanced stage ovarian cancer”, which represented 3.3% of patients in the cohort.

Funding

Merck KGaA Pfizer

History